Literature DB >> 6447475

Susceptibilities of anaerobic bacteria to cefoperazone and other antibiotics.

D Kaye, W Kobasa, K Kaye.   

Abstract

Two hundred fifty clinical isolates of anaerobic bacteria were tested for suceptibility to cefoperazone, cefamandole, cefoxitin, carbenicillin, clindamycin, and chloramphenicol. Anaerobic gram-positive cocci were susceptible to all of the antibiotics tested. Clindamycin was the most active agent against Bacteroides species, followed by chloramphenicol and then cefoxitin. Cefoperazone was less active than cefoxitin and equal in activity to carbenicillin. Cefamandole was the least active antibiotic against Bacteroides. B. distasonis, B. vulgatus, B. thetaiotaomicron, and B. ovatus were more resistant to the antibiotics than B. melaninogenicus, B. oralis, or B. bivius. Clindamycin was the most active agent against Clostridium species, followed by chloramphenicol; the three cephalosporins and carbenicillin were about equal in activity. Clindamycin was the most active antibiotic against Fusobacterium species, followed by chloramphenicol, carbenicillin, and cefoperazone (which were about equally active) and then cefamandole.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6447475      PMCID: PMC283910          DOI: 10.1128/AAC.17.6.957

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  3 in total

1.  Collaborative evaluation of a proposed reference dilution method of susceptibility testing of anaerobic bacteria.

Authors:  V L Sutter; A L Barry; T D Wilkins; R J Zabransky
Journal:  Antimicrob Agents Chemother       Date:  1979-10       Impact factor: 5.191

2.  Comparative activity and beta-lactamase stability of cefoperazone, a piperazine cephalosporin.

Authors:  H C Neu; K P Fu; N Aswapokee; P Aswapokee; K Kung
Journal:  Antimicrob Agents Chemother       Date:  1979-08       Impact factor: 5.191

3.  In vitro antibacterial activity of cefoperazone (T-1551), a new semisynthetic cephalosporin.

Authors:  N Matsubara; S Minami; T Muraoka; I Saikawa; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191

  3 in total
  20 in total

1.  Predicting the susceptibility of anaerobes to cefoperazone, cefotaxime, and cefoxitin with the thioglycolate broth disk procedure.

Authors:  R J Zabransky; R J Birk; T A Kurzynski; K L Toohey
Journal:  J Clin Microbiol       Date:  1986-08       Impact factor: 5.948

2.  Factors affecting the in vitro activity of cefoperazone against the Bacteroides fragilis group.

Authors:  V L Sutter; Y Y Kwok
Journal:  Antimicrob Agents Chemother       Date:  1981-12       Impact factor: 5.191

3.  Comparative in vitro activities of cefpiramide and apalcillin against anaerobic bacteria.

Authors:  H Wexler; W T Carter; B Harris; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1984-02       Impact factor: 5.191

4.  Treatment of gram-negative bacillary septicemia with cefoperazone.

Authors:  H Lagast; F Meunier-Carpentier; J Klastersky
Journal:  Eur J Clin Microbiol       Date:  1983-12       Impact factor: 3.267

5.  Comparative in vitro activity of new beta-lactam antibiotics against anaerobic bacteria.

Authors:  R D Rolfe; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1981-11       Impact factor: 5.191

6.  Comparative in vitro activity of cefbuperazone against anaerobic bacteria isolated from community hospitals.

Authors:  E J Goldstein; D M Citron
Journal:  Antimicrob Agents Chemother       Date:  1985-02       Impact factor: 5.191

7.  Antimicrobial susceptibilities of anaerobic bacteria isolated from female genital tract infections.

Authors:  G B Hill; O M Ayers
Journal:  Antimicrob Agents Chemother       Date:  1985-03       Impact factor: 5.191

8.  Role of Bacteroides bivius beta-lactamase in beta-lactam susceptibility.

Authors:  J M Lacroix; F Lamothe; F Malouin
Journal:  Antimicrob Agents Chemother       Date:  1984-11       Impact factor: 5.191

9.  Comparative in vitro activity of ceftizoxime, cefoperazone, and cefoxitin against anaerobic bacteria.

Authors:  M W Drulak; A W Chow
Journal:  Antimicrob Agents Chemother       Date:  1981-11       Impact factor: 5.191

10.  Comparison of susceptibilities of anaerobic bacteria to cefmenoxime, ceftriaxone, and other antimicrobial compounds.

Authors:  H M Pollock; J Holt; C Murray
Journal:  Antimicrob Agents Chemother       Date:  1983-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.